WASHINGTON (Reuters) - The Federal Trade Commission (FTC) voted unanimously Thursday to increase scrutiny of pharmacy benefit managers that act as mid.
WASHINGTON (Reuters) - The Federal Trade Commission (FTC) voted unanimously Thursday to increase scrutiny of pharmacy benefit managers that act as mid.
The U.S. Federal Trade Commission said it is probing how big pharmacy benefit managers, such as at CVS Caremark, are influenced in terms of pricing and patients' access to medications